PTGS2 and treatment resistant depression: Celecoxib, is a cyclooxygenase-2 (COX-2) inhibitor, that suppresses pro-inflammatory cytokine release [203], while minocycline, a potentially effective antidepressant for TRD, is a tetracycline antibiotic with anti-inflammatory, antioxidant, and neuroprotective properties [282].